EP2796132
Lækningar á taugaröskunum sem byggja á baklófeni og akamprósati
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.3.2012EP published:
2.5.2018EP application number:
13196468.6
EP translation filed:
20.6.2018Grant published:
15.7.2018EPO information:
European Patent Register
Max expiry date:
29.2.2032Expiry date:
28.2.2024
Title:
Baclofen and acamprosate based therapy of neurological disorders
Timeline
Today
1.3.2012EP application
2.5.2018EP Publication
20.6.2018Translation submitted
15.7.2018Registration published
28.2.2024Expires
Owner
Name:
PharnextAddress:
11, rue des Peupliers, 92130, Issy-les-Moulineaux, FR
Inventor
Name:
Cohen, DanielAddress:
Saint Cloud, FR
Name:
Chumakov, IlyaAddress:
Vaux Le Penil, FR
Name:
Nabirochkin, SergueiAddress:
Chatenay Malabry, FR
Name:
Vial, EmmanuelAddress:
Nice, FR
Name:
Guedj, MickaëlAddress:
Paris, FR
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
11305217Date:
1.3.2011Country:
EP
Number:
201161468658 PDate:
29.3.2011Country:
US
Number:
11305687Date:
6.6.2011Country:
EP
Number:
201161493606 PDate:
6.6.2011Country:
US
Classification
Categories:
A61K 31/137, A61K 31/138, A61K 31/185, A61K 31/195, A61K 31/42, A61K 31/64, A61P 25/16, A61P 25/28, A61P 25/00, A61K 31/145, A61K 31/164, A61K 31/44, A61K 31/445, A61K 9/20, A61K 31/428
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 27.3.2019
Expires: 29.2.2020
Payer: Tego ehf.
Number: 9
Paid: 20.3.2020
Expires: 28.2.2021
Payer: Tego ehf.
Number: 10
Paid: 22.3.2021
Expires: 28.2.2022
Payer: Tego ehf.
Number: 11
Paid: 21.3.2022
Expires: 28.2.2023
Payer: Tego IP ehf.
Number: 12
Paid: 30.3.2023
Expires: 28.2.2024
Payer: Tego IP ehf.